Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Download Brochure MALDI PharmaPulse is a complete mass ...

VIENNA--(BUSINESS WIRE)-- Prior to the 20 th Annual Meeting of the European Society of Clinical Microbiology and Infectious Diseases on April 10-13, 2010 in Vienna, Bruker Daltonics and KIESTRA Lab ...

Bruker Corporation BRKR recently announced the launch of the neofleX Imaging Profiler for mass spectrometry-based tissue imaging at the 72nd ASMS meeting. The novel, high-performance MALDI-TOF/TOF ...

ORLANDO, Fla.--(BUSINESS WIRE)--Feb. 28, 2005--At Pittcon 2005, Bruker Daltonics Inc., an operating company of Bruker BioSciences Corporation (NASDAQ: BRKR), today announces novel smartbeam(TM) laser ...

MALDI-TOF mass spectrometry is increasingly being applied as a clinical research tool in biomarker discovery, clinical proteomics, functional genomics, molecular imaging, and microorganism ...

Bruker announced its new MALDI PharmaPulse 2.0 solution (MPP 2.0), which enhances the automation capabilities of the rapifleX MALDI-TOF mass spectrometer, with its proprietary scanning 10 kHz ...

Bruker's Biotyper enables molecular identification and taxonomical classification of bacteria, yeasts and fungi reliably and quickly using proteomic fingerprinting by high-throughput MALDI-TOF mass ...

The firm bought selected assets in Glasgow, UK for the development, validation and commercialization of molecular assays for applications in microbiology. It includes lab infrastructure and IP in the ...

The rapifleX MALDI PharmaPulse (MPP) accelerates label-free hit finding in drug discovery: rapifleX MPP combines the unambiguousness of mass spectrometry with the required speed to comb through large ...